Haemonetics (HAE)

• Market cap: $3.17B
• 1 day: -0.83%
• 5 days: -0.46%
• 1 month: -3.17%
• 3 months: -19.62%
• 6 months: -20.23%
• Year to date: -19.62%
• 1 year: -25.68%
• 5 years: -31.22%
• 10 years: 41.75%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

38% more repeat investments, than reductions

Existing positions increased: 123 | Existing positions reduced: 89

33% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]

20% more first-time investments, than exits

New positions opened: 49 | Existing positions closed: 41

4.34% more ownership

Funds ownership: 108.49% [Q3] → 112.83% (+4.34%) [Q4]

2% more call options, than puts

Call options by funds: $42.5M | Put options by funds: $41.7M

1% more funds holding

Funds holding: 303 [Q3] → 306 (+3) [Q4]

1% less capital invested

Capital invested by funds: $4.46B [Q3] → $4.42B (-$36M) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $95 51% upside
• Avg. target: $104 64% upside
• High target: $115 82% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Needham Mike Matson 40% 1-year accuracy 50 / 124 met price target	65% upside $104	Buy Maintained	18 Mar 2025
Raymond James Andrew Cooper 13% 1-year accuracy 2 / 16 met price target	82% upside $115	Strong Buy Reiterated	7 Feb 2025
JMP Securities David Turkaly 31% 1-year accuracy 8 / 26 met price target	59% upside $100	Market Outperform Maintained	7 Feb 2025
Barrington Research Michael Petusky 35% 1-year accuracy 25 / 72 met price target	51% upside $95	Outperform Maintained	7 Feb 2025